PhaseBio Pharmaceuticals Inc. (PHAS) Dipped -13.71% or -0.65 To Price $4.09 On Tuesday


PhaseBio Pharmaceuticals Inc. (PHAS) dipped -13.71% or -0.65 to $4.09. It is close to 85938 shares traded, which is 85.45% compare to the average total volume 100571. The market cap of PHAS is $97.36 million. The year to date change is -18.91%. The 52 week price range is from $4.03 to $6.0. Price of PHAS have changed -5.20% during last week. It have changed -5.20% over last month, -5.20% over last 3 months, -5.20% over last 6 months and -5.20% over one year.

The 52-week High is 6.0. It is 46.70% from the current price. The 52-week Low is 4.03. It is -1.47% from current price.

There are some statistics of PHAS. It is has market cap $97.36 million. The share outstanding is 23.80 million. The average volume is 100571. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is -51.73%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -35.57%.


Tags:

Share this post